Multiply Labs reduces biomanufacturing costs by 74% with UR cobots

Multiply Labs made use of cobots to provide development lead to the production of cell treatments. Resource: Universal Robots

Accuracy medication, in which facility therapies for cancer cells and various other problems are individualized, is usually pricey, restricting individual accessibility to care. Multiply Labs Inc. has actually created a “robot biomanufacturing collection” that it stated can decrease the expense of life-saving cell treatments by 74%.

” Historically, cell and genetics treatment production has actually been hand-operated, practically artisanal,” stated Fred Parietti, Chief Executive Officer of Multiply Labs. “Professional researchers carry out numerous jobs by hand, from pipetting to drinking cells.”

San Francisco-based Multiply Labs has actually created cloud-controlled automated systems for the manufacturing of personalized medicines at range. Its group consists of mechanical designers, electric designers, computer system researchers, software program designers, and pharmaceutical researchers.

The firm stated its clients consist of several of biggest international companies in the sophisticated pharmaceutical production room.

Custom-made treatments require exact manufacturing

Customized cell treatments are usually made use of to deal with blood cancers cells such as lymphoma and leukemia. Unlike mass-produced medicines, they call for a tailored dosage from each individual’s very own cells, making large-batch manufacturing difficult. Such treatments are presently valued in between $300,000 and $2 million per dosage.

Furthermore, a solitary microbial contamination can make the whole item pointless, bring about pricey production failings.

Multiply Labs selected Universal Robots A/S (UR) for its modular biomanufacturing collection after carefully reviewing numerous various collective robotic arms.

” UR was picked because of their critical six-axis abilities, unequaled pressure setting for fragile handling, smooth software program assimilation, durable area assistance, and cleanroom compatibility,” stated Nadia Kreciglowa, head of robotics at Multiply Labs.

Editor’s note: RoboBusiness 2025, which will certainly get on Oct. 15 and 16 in Santa Clara, Calif., will certainly consist of tracks on physical AI, making it possible for modern technologies, and layout and advancement ideal techniques. It will certainly be co-located with clinical gadget occasion DeviceTalks West, and enrollment is currently open.

UR cobots can reproduce detailed procedures

As released in peer-reviewed research studies with the College of The Golden State, San Francisco (UCSF), Multiply Labs made use of numerous UR cobots operating in parallel, piled flooring to ceiling with accident evasion, to manage the whole cell treatment production procedure.

The brand-new collaboration, Universal Robots’ very first in the cell and genetics treatment industry, highlights the fantastic possibility of collective robotics in health care, according to Jean-Pierre Hathout, head of state of Odense, Denmark-based UR, a Teradyne firm.

” By equipping Multiply Labs to reproduce detailed hand-operated procedures with high accuracy and range, our cobots are redefining effectiveness in pharmaceutical production,” he specified. “Much more notably, it’s driving considerable expense decreases while widening accessibility to life-saving therapies. At its core, this collaboration is a testimony to just how robotics can raise human capacity and offer essential requirements in medication.”

Multiply Labs makes use of replica discovering for procedure integrity

Multiply Labs mentioned its replica finding out innovation as making it possible for robotics gain from professional human demos as opposed to determining brand-new procedures.

” We ask the pharmaceutical firms that we deal with to video their researchers carrying out the jobs,” clarified Parietti. “We after that feed this information to the robotics, and the robotics discover to properly reproduce what researchers were carrying out in the laboratory, simply extra effectively, extra repeatably, 24/7, and in parallel.”

He included that this technique permits the UR cobots to “self-learn numerous brand-new jobs” with significantly reduced design prices.

Multiply Labs’ system consistently reproduces hand-operated procedures with boosted effectiveness, repeatability, and hygienic problems, according to the companions. This procedure integrity is likewise critical for regulative conformity, possibly conserving years and billions of bucks in re-approval prices by reproducing existing, currently authorized procedures, stated Dr. Jonathan Esensten, supervisor of the Advanced Biotherapy Facility at Sheba Medical Facility.

” As opposed to beginning with square no in regards to medication authorization, firms can currently record that this is the precise very same production procedure. It simply occurs to be done by a robotic.” he kept in mind. Dr. Esensten, a previous participant of the UCSF professors, dealt with Multiply Labs to create the system.

Multiply Labs makes use of replica finding out to educate robotics just how to do brand-new jobs. Resource: Universal Robots

Multiply Labs lowers prices, room use, contamination

” When we contrasted a conventional hand-operated production procedure for these cell treatments to a robot procedure doing the precise very same procedure, we discovered an expense decrease of roughly 74%,” stated Esensten. “Expanding T cells is something that we have actually been providing for a long period of time, however to have the robot system do it with no human hands touching the cells throughout the procedure, that is a radical change in regards to having the ability to produce these medications at a reduced expense and in a smaller sized room.”

Along with set you back financial savings, the robot system can considerably boost room use, Parietti stated. It can liberate sufficient room to accumulate to 100x even more individual dosages per square foot of cleanroom compared to a common guidebook procedure. Quality and sterility are likewise dramatically boosted, he stated.

” Robotics do not take a breath, and they do not touch things they’re not intended to touch,” observed the Multiply Labs Chief Executive Officer.

” While human handling resulted in contamination in one instance, we did not see any kind of contamination in the robot procedure,” stated Dr. Esensten of the UCSF research.

The Multiply Labs robot collection is currently released at international pharmaceutical firms with outcomes currently likewise recorded in cooperation with researchers at Stanford College.

” This will actually transform the means we think of the production of these bespoke, custom-made cell and genetics treatments for people,” stated Parietti. “We will inevitably boost individual gain access to worldwide by decreasing production prices, making it possible for dispersed manufacturing worldwide of these life-saving treatments.”

The message Multiply Labs lowers biomanufacturing prices by 74% with UR cobots showed up initially on The Robotic Record.